Skip to main content
US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
YC

YCBDStock

NYSE American · Healthcare

$0.416 last close 2026-11-06
Open in terminalCompare
Alert

Verdicts genuinely change. Free email alert the moment YCBD's does — no target price to set, unlike "Alert" above.

Sharia status
NOT YET SCREENED
Not screened yet — no methodology has been established for this symbol
3 of 3 pass our own screen — 4 of 7 could not be computed
HTR non-permissible income <0.01%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No active setup right now. The technical picture doesn't show a clear edge — check back when the trend or momentum shifts.

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure4 of 5 timeframes bullish · 73.9% aligned
VWAPPrice holding above VWAP ($0.41)
VolumeRelative volume 7.7× the 20-day average
Momentum10-day rate of change +14.7%
Market & analysts
Wall Street consensus
SELL
6 analysts
Institutional own.
7.9%
of shares
Momentum (10d)
+14.7%
rate of change
SMC grade
D · 41
73.9% aligned
0.18% *
Purification ratio (secondary provider, uncertain)
<0.01%
Non-permissible income — HTR, from filings (2026-06-30)
D · 41
SMC grade — 73.9% timeframe alignment
+14.7%
Rate of change (10d)
SELL
Wall Street consensus (6)
7.9%
Institutional ownership

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-06-30. These ratios come from the issuer's own published statements rather than structured SEC data.

Business activity: not screened

We have not screened this company's line of business, so these ratios say nothing about whether what it does is permissible.

AAOIFI Unverified⚠️ implied interest rate too low — debt may be double-counted 1 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 72.53% 30.00% Fail
Interest-bearing investments 42.88% 30.00% Fail
Non-permissible income 0.00% 5.00% Pass
Usmani Pass 4 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 27.26% 33.00% Pass
Interest-bearing investments 16.11% 33.00% Pass
Non-liquid assets 76.84% at least 20.00% Pass
Non-permissible income 0.00% 5.00% Pass
MSCI Pass 4 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 27.26% 33.33% Pass
Cash + interest-bearing securities 16.11% 33.33% Pass
Accounts receivable 23.16% 33.33% Pass
Non-permissible income 0.00% 5.00% Pass
FTSE Pass 4 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 10.48% 33.33% Pass
Cash + interest-bearing securities 16.11% 33.33% Pass
Accounts receivable 23.16% 50.00% Pass
Non-permissible income 0.00% 5.00% Pass
Dow Jones Islamic Market Unverified⚠️ implied interest rate too low — debt may be double-counted 2 of 4 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 64.05% 33.00% Fail
Cash + interest-bearing securities 37.87% 33.00% Fail
Accounts receivable 16.57% 33.00% Pass
Non-permissible income 0.00% 5.00% Pass
S&P Shariah Unverified⚠️ implied interest rate too low — debt may be double-counted 3 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 77.24% 33.00% Fail
Cash + interest-bearing securities 45.67% 49.00% Pass
Accounts receivable 19.98% 49.00% Pass
Non-permissible income 0.00% 5.00% Pass
MSCI M-Series Unverified⚠️ implied interest rate too low — debt may be double-counted 1 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 77.24% 33.33% Fail
Cash + interest-bearing securities 45.67% 33.33% Fail
Accounts receivable 65.65% 49.00% Fail
Non-permissible income 0.00% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

Usmani (% of total assets)non permissible income ratio 5.0pts
MSCI Islamic Index (% of total assets)non permissible income ratio 5.0pts
FTSE Shariah Global Equity Index Series (% of total assets)non permissible income ratio 5.0pts

The numbers the ratios are built from

Read from YCBD's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $19.2M 2026-06-30 Revenues
Interest-bearing debtShort and long-term borrowings $1.4M 2026-06-30 ConvertibleLongTermNotesPayable (stale, beyond normal quarterly tolerance)
Cash and interest-bearing securitiesCash, equivalents and marketable securities $2.1M 2026-06-30 CashAndCashEquivalentsAtCarryingValue
Total assetsBalance sheet total $13.1M 2026-06-30 Assets
Market capDenominator for AAOIFI $4.9M live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $4.7M 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $5.9M 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $0 2026-06-30 no interest-income tag reported in 3+ years (treated as $0)

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

What changed, and when

Verdict history for YCBD. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-09-07 No change recorded No verdict change for YCBD has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.

ℹ️ no compliance scan has run for 5 days - this is not a reading of today

2.271.791.310.830.352025-11-072026-05-112026-11-06

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
0.34
S2
0.36
S1
0.37
PIVOT
0.40
R1
0.41
R2
0.43
R3
0.45

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
0.3502 – 0.5618
±23.21% from 0.456, made 2026-10-04 · resolves 2026-10-11
STRONG SELL
from 19 indicators
61.9% of our last 5789 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 49.9% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

BUY
19 indicators
OscillatorsSTRONG BUY
3 buy · 3 neutral · 1 sell
Moving averagesNEUTRAL
6 buy · 0 neutral · 6 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)54.40NEUTRAL
Stochastic %K (14)64.22NEUTRAL
CCI (20)121.73SELL
Williams %R (14)-35.78NEUTRAL
MACD (12,26,9)0.01BUY
ROC (10)14.60BUY
Momentum (10)0.05BUY
EMA (10)0.39BUY
SMA (10)0.39BUY
EMA (20)0.39BUY
SMA (20)0.38BUY
EMA (30)0.40BUY
SMA (30)0.40BUY
EMA (50)0.43SELL
SMA (50)0.43SELL
EMA (100)0.51SELL
SMA (100)0.51SELL
EMA (200)0.64SELL
SMA (200)0.65SELL

About YCBD

Healthcare · Drug Manufacturers - Specialty & Generic

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is based in Charlotte, North Carolina.

cbdmd.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Grade verdict

Weak — low conviction, small size or skip

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BULLISH 44
⏰ 4H NEUTRAL 18
🕐 1H BULLISH 72
⏱ 15-Min BULLISH 130
⏲ 5-Min BULLISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

+14.7%
Rate of change (10d)
7.7×
Volume vs its 20-day average
-0.01
MACD (no fresh cross)

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-03 · Asset managers net 928584 (+5135)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.